FDA reviewers back Pfizer/BioNTech COVID-19 vaccine ahead of panel
pharmaphorum
DECEMBER 9, 2020
Reviewers from the FDA have given their blessing to the Pfizer/BioNTech COVID-19 vaccine ahead of a key meeting tomorrow – but the regulator noted that there are still uncertainties about whether the shot can stop the disease from spreading. of participants.
111 
Let's personalize your content